47
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Plasticity of cancer cell invasion: Patterns and mechanisms

      review-article
      a , 1 , 2 , b , 1 , 3 , a , 2 , a , 2 , a , * , a , *
      Translational Oncology
      Neoplasia Press
      ECM, extracellular matrix, EMT, epithelial-to-mesenchymal transition, CTC, circulating tumor cells, ROCK, Rho-associated kinase, FAK, focal adhesion kinase, MMPs, matrix metalloproteinases, MAT, mesenchymal-amoeboid transition, AMT, amoeboid-mesenchymal transition, BM-MSCs, bone marrow-derived mesenchymal stem cells, CMT, collective-mesenchymal transition, CAT, collective-amoeboid transition, YAP, Yes-associated protein, TGFBR1, TGF-beta type-I receptor, MCT, mesenchymal-collective transition, ACT, amoeboid-collective transition, Cancer cell invasion, Amoeboid cell migration, Mesenchymal cell migration, Mesenchymal-amoeboid transition, Amoeboid-mesenchymal transition

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cancer cell migration and invasion are integral components of metastatic disease, which is the major cause of death in cancer patients. Cancer cells can disseminate and migrate via several alternative mechanisms including amoeboid cell migration, mesenchymal cell migration, and collective cell migration. These diverse movement strategies display certain specific and distinct hallmarks in cell-cell junctions, actin cytoskeleton, matrix adhesion, and protease activity. During tumor progression, cells pass through complex microenvironments and adapt their migration strategies by reversible mesenchymal-amoeboid and individual-collective transitions. This plasticity in motility patterns enables cancer cells disseminate further and thus limit the efficiency of anti-metastasis therapies. In this review, we discuss the modes and mechanisms of cancer cell migration and focus on the plasticity of tumor cell movement as well as potential emerging therapeutic options for reducing cancer cell invasion.

          Graphical abstract

          Highlights

          • Cancer cells can disseminate via amoeboid cell migration, mesenchymal cell migration or collective cell migration.

          • Tumor microenvironment and certain therapeutic challenge can trigger the transitions of migration patterns.

          • Plasticity of cancer cells migration limit efficiency of anti-metastasis therapies.

          • Combination therapy targeting different migration is a promising anti-metastasis therapy.

          Related collections

          Most cited references91

          • Record: found
          • Abstract: found
          • Article: not found

          Initial steps of metastasis: Cell invasion and endothelial transmigration

          Metastasis is the leading cause of cancer mortality. The metastatic cascade represents a multi-step process which includes local tumor cell invasion, entry into the vasculature followed by the exit of carcinoma cells from the circulation and colonization at the distal sites. At the earliest stage of successful cancer cell dissemination, the primary cancer adapts the secondary site of tumor colonization involving the tumor–stroma crosstalk. The migration and plasticity of cancer cells as well as the surrounding environment such as stromal and endothelial cells are mandatory. Consequently, the mechanisms of cell movement are of utmost relevance for targeted intervention of which three different types have been reported. Tumor cells can migrate either collectively, in a mesenchymal or in an amoeboid type of movement and intravasate the blood or lymph vasculature. Intravasation by the interaction of tumor cells with the vascular endothelium is mechanistically poorly understood. Changes in the epithelial plasticity enable carcinoma cells to switch between these types of motility. The types of migration may change depending on the intervention thereby increasing the velocity and aggressiveness of invading cancer cells. Interference with collective or mesenchymal cell invasion by targeting integrin expression or metalloproteinase activity, respectively, resulted in an amoeboid cell phenotype as the ultimate exit strategy of cancer cells. There are little mechanistic details reported in vivo showing that the amoeboid behavior can be either reversed or efficiently inhibited. Future concepts of metastasis intervention must simultaneously address the collective, mesenchymal and amoeboid mechanisms of cell invasion in order to advance in anti-metastatic strategies as these different types of movement can coexist and cooperate. Beyond the targeting of cell movements, the adhesion of cancer cells to the stroma in heterotypic circulating tumor cell emboli is of paramount relevance for anti-metastatic therapy.
            • Record: found
            • Abstract: found
            • Article: not found

            Cancer invasion and the microenvironment: plasticity and reciprocity.

            Cancer invasion is a cell- and tissue-driven process for which the physical, cellular, and molecular determinants adapt and react throughout the progression of the disease. Cancer invasion is initiated and maintained by signaling pathways that control cytoskeletal dynamics in tumor cells and the turnover of cell-matrix and cell-cell junctions, followed by cell migration into the adjacent tissue. Here, we describe the cell-matrix and cell-cell adhesion, protease, and cytokine systems that underlie tissue invasion by cancer cells. We explain how the reciprocal reprogramming of both the tumor cells and the surrounding tissue structures not only guides invasion, but also generates diverse modes of dissemination. The resulting "plasticity" contributes to the generation of diverse cancer invasion routes and programs, enhanced tumor heterogeneity, and ultimately sustained metastatic dissemination. Copyright © 2011 Elsevier Inc. All rights reserved.
              • Record: found
              • Abstract: found
              • Article: not found

              Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.

              Imaging of collectively invading cocultures of carcinoma cells and stromal fibroblasts reveals that the leading cell is always a fibroblast and that carcinoma cells move within tracks in the extracellular matrix behind the fibroblast. The generation of these tracks by fibroblasts is sufficient to enable the collective invasion of the squamous cell carcinoma (SCC) cells and requires both protease- and force-mediated matrix remodelling. Force-mediated matrix remodelling depends on integrins alpha3 and alpha5, and Rho-mediated regulation of myosin light chain (MLC) activity in fibroblasts, but these factors are not required in carcinoma cells. Instead, carcinoma cells use Cdc42 and MRCK (myotonic dystrophy kinase-related CDC42-binding protein kinases) mediated regulation of MLC to follow the tracks generated by fibroblasts.

                Author and article information

                Contributors
                Journal
                Transl Oncol
                Transl Oncol
                Translational Oncology
                Neoplasia Press
                1936-5233
                17 October 2020
                January 2021
                17 October 2020
                : 14
                : 1
                : 100899
                Affiliations
                [a ]State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China
                [b ]Department of Head and Neck Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China
                Author notes
                [* ]Corresponding authors at: State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology (Sichuan University), Chengdu, Sichuan 610041, China. tangyaling@ 123456scu.edu.cn lxh88866@ 123456scu.edu.cn
                [1]

                These authors contributed equally to this work.

                [2]

                Post address: State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology (Sichuan University), Chengdu Sichuan 610041, China.

                [3]

                Post address: Department of Head and Neck Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, China.

                Article
                S1936-5233(20)30391-0 100899
                10.1016/j.tranon.2020.100899
                7573380
                33080522
                48361c48-6726-450c-85b6-75852e51e321
                © 2020 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc. CC BY-NC-ND 4.0.

                This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

                History
                : 2 August 2020
                : 12 September 2020
                : 23 September 2020
                Categories
                Review article

                ecm, extracellular matrix,emt, epithelial-to-mesenchymal transition,ctc, circulating tumor cells,rock, rho-associated kinase,fak, focal adhesion kinase,mmps, matrix metalloproteinases,mat, mesenchymal-amoeboid transition,amt, amoeboid-mesenchymal transition,bm-mscs, bone marrow-derived mesenchymal stem cells,cmt, collective-mesenchymal transition,cat, collective-amoeboid transition,yap, yes-associated protein,tgfbr1, tgf-beta type-i receptor,mct, mesenchymal-collective transition,act, amoeboid-collective transition,cancer cell invasion,amoeboid cell migration,mesenchymal cell migration,mesenchymal-amoeboid transition,amoeboid-mesenchymal transition

                Comments

                Comment on this article

                Related Documents Log